Cross-institution positioning
Jul 27, 2026Strong institutional reduction. 1 reducing, 2 exited across 3 comparable institutions.
Source: Schedule 13 researchALDX Institutional Ownership
Aldeyra Therapeutics, Inc.
Latest stored close $0.96 as of Oct 7, 2026 View live quote ↗
STOCKNODE Outlook
Sell
35/100
3 tracked · 3 comparable
Latest filing
Jul 27, 2026
Positive breadth
0 positive · 3 negative
Recent close
$0.96
Research confidence
Medium
Institutional Research 16/100 · 0 accumulating · 3 reducing / exited
Ownership history
Reported ownership % history
Latest filing Jul 27, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating0
Newly reported0
Reducing / exited
3
52-week position
—
Institutional Intelligence
Why STOCKNODE says Sell
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Sell 35/100
Confidence:Medium
Why this signal
- 0 tracked institutions accumulating versus 3 reducing/exited.
- 1 tracked institution recently reversed from reducing to accumulating.
- Comparable SEC fundamentals are improving.
Conflicting evidence
- Institutions are reducing while comparable SEC fundamentals are improving.
Institutional
17/100
Insiders
59/100
Fundamentals
70/100
Events
50/100
Quarterly 13F activity
Jun 30, 20260 increased/new, 2 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Jun 9, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 1 purchase by 1 reporting owner and 0 sales by 0 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Sep 29, 20263 non-amendment material events in the last 90 days; Latest classified evidence: Regulation FD disclosure. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 6, 2026Net income +44.2% YoY; Free cash flow +46.5% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 6% through its reported 52-week range; -73.1% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from BlackRock.
Filed Jul 27, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Jul 27, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
BlackRock
Filed Jan 29, 2024
Direction locked
BlackRock
Filed Jul 27, 2026
Direction locked
Vanguard Group
Filed Mar 26, 2026
Direction locked
State Street
Filed Feb 3, 2023
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
BlackRock
Filed Jan 29, 2024
BlackRock
Filed Jul 27, 2026
Vanguard Group
Filed Mar 26, 2026
State Street
Filed Feb 3, 2023
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales00 reporting owner(s)
90-day purchase breadth1
90-day sale breadth0
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Miller-Rich Nancy | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 3.3K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Miller-Rich Nancy | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | DOUGLAS RICHARD | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 2.3K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | DOUGLAS RICHARD | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 19.9K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | DOUGLAS RICHARD | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Phillips Gary M. | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 5.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Phillips Gary M. | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 6.6K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Phillips Gary M. | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Clark William D | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 2.3K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Clark William D | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Walker Neal | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 3.3K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Walker Neal | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Bronstein Ben | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 5.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Bronstein Ben | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 5.3K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | Bronstein Ben | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 70.0K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | DEPTULA-HICKS DARLENE M | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 9.8K | $0.00 | Direct | Jun 11, 2026 |
| Jun 9, 2026 | DEPTULA-HICKS DARLENE M | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 84.6K | $0.00 | Direct | Jun 11, 2026 |
| Jun 3, 2026 | Brady Todd C | POpen-market or private purchase | Common Stock | 250.0K | $1.67 | Direct | Jun 5, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events1
90-day capital-related0
90-day equity-related0
90-day debt-related0
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 29, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Jul 30, 2026 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| Jul 15, 2026 | 8-K | 8.01 | Other event | — | Filing |
| Jun 10, 2026 | 8-K | 5.02, 5.07, 7.01, 9.01 | Director or executive change; Shareholder vote results; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 1, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Apr 20, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Apr 1, 2026 | 8-K | 8.01 | Other event | — | Filing |
| Mar 17, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Feb 27, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Dec 31, 2025 | 8-K | 5.02 | Director or executive change | — | Filing |
| Dec 16, 2025 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Nov 13, 2025 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Operating income
$-5.9M
Q2 2026
+42.5% YoY 10-Q filed Aug 6, 2026
Net income
$-5.5M
Q2 2026
+44.2% YoY 10-Q filed Aug 6, 2026
Diluted EPS
$-0.09
Q2 2026
+43.8% YoY 10-Q filed Aug 6, 2026
Operating cash flow
$-9.7M
YTD through Jun 30, 2026
+53.9% YoY 10-Q filed Aug 6, 2026
Free cash flow
$-30.3M
FY 2024
+46.5% YoY 10-K filed Feb 28, 2025
Cash & equivalents
$70.0M
As of Dec 31, 2025
+28.5% YoY 10-K filed Feb 27, 2026
Long-term debt
$15.3M
As of Mar 31, 2026
+1.3% YoY 10-Q filed May 7, 2026
Assets
$47.5M
As of Jun 30, 2026
-44.0% YoY 10-Q filed Aug 6, 2026
Liabilities
$9.7M
As of Jun 30, 2026
-67.5% YoY 10-Q filed Aug 6, 2026
Stockholders’ equity
$37.9M
As of Jun 30, 2026
-31.5% YoY 10-Q filed Aug 6, 2026
Shares outstanding
60.3M
As of Aug 4, 2026
+0.7% YoY 10-Q filed Aug 6, 2026
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$1.37
View live quote ↗
52-week low
$1.07
Mar 17, 2026
52-week high
$5.93
Jan 30, 2026
Below 52-week high
76.9%
1W return
-11.0%
1M return
-12.2%
3M return
-22.2%
6M return
-66.8%
YTD return
-73.6%
1Y return
-73.1%
30-day volatility
57.9%
90-day volatility
75.7%
1Y max drawdown
-78.4%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 12 filing(s) · 9 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 27, 2026 filed · 27d Schedule 13G amendment | Earliest Schedule 13G amendment found | 1.0M | 12.00% | $2.13 | $1.59 | $0.96 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 26, 2026 filed · 13d Schedule 13G amendment | Exit below reporting threshold | 0 -3.9M | 0.00% -6.68 pts | $4.13 | $1.84 | $0.96 |
| BlackRock CIK0002012383 | Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 3.7M | $5.39 | $4.41 | $0.96 |
Explore more institutional activity
Related research
Compare ALDX with other securities showing similar institutional activity or recent accumulation across several tracked institutions.